Reported Jul 29, 2026 · Ongoing · Updated Sep 16, 2026

Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma…

Supernus Pharmaceuticals, Inc.

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Supernus Pharmaceuticals, Inc. · 9715 Key West Ave · Rockville, MD · 20850-3900

Is this the product you have?

  • Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only
  • Manufactured byCatalent Pharma Solutions, Winchester, KY 40391 USA
  • Manufactured forSupernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30
Lot codes and dates
  • Lot # 2075801
  • Exp Date31-Oct-2029
Amount recalled
15,853 bottles

Where it was sold

  • Nationwide

Why it was recalled

Failed Dissolution Specifications

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Supernus Pharmaceuticals, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (Enforcement Report)

Read the FDA (weekly enforcement report) notice

Notice updated Aug 11, 2026 · Data as of Sep 19, 5:38 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.